Home Latest Articles
Latest Articles
  • Chao DONG, Hanyue YANG, Xianguang YAN, shubo DONG, Dahua SHI
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 221-226.

    In this article, based on the industrial synthetic route of alogliptin benzoate(1), seven related substances of 1 were synthesized, namely 2,2'-[[6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1,5(2H)-diyl]-bis(methylene)]-dibenzonitrile(7), 2-[[5-bromo-6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl]-methyl]benzonitrile(8), 2,2'-[[6-ethoxy-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1,5(2H)-diyl]bis(methylene)]-dibenzonitrile(9), (R)-2-[[3-methyl-2,4-dioxo-6-[(piperidin-3-yl)amino]-3,4-dihydropyrimidine-1(2H)-yl]methyl]-benzonitrile(10), (R)-2-[[6-[3-[[3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl]amino]-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl]methyl]benzonitrile(11), (R)-2-[[3-methyl-6-[3-[(1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]piperidin-1-yl]-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl]methyl]benzonitrile(12), (R)-N-[1-[3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl]piperidin-3-yl]benzamide(13). Their structures were confirmed by 1H NMR, 13C NMR and MS. The synthesis of 7, 9, 12, and 13 were reported at the first time.

  • Zhen LI, Sujie CHEN, Guoquan ZHAO
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 227-234.

    Eight related substances of ceritinib(1) were prepared according to its structure and synthetic process, namely 5-chloro-2-isopropoxy-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine(related substance A), 5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-ol(related substance B), 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N4-[2-(isopropylsulfinyl)phenyl]pyrimidine-2,4-diamine(related substance C), 5-chloro-N2-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N4-[2-(propylsulfonyl)phenyl]pyrimidine-2,4-diamine(related substance D), 5-chloro-N4-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N2-[2-(isopropylsulfonyl)phenyl]-pyrimidine-2,4-diamine(related substance E), 2-[[5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-yl]amino]-4-methyl-5-(piperidin-4-yl)phenol(related substance F), 4-[4-[4-[[5-chloro-4-[[2-(isopropylsulfonyl)-phenyl]amino]pyrimidin-2-yl]amino]-5-isopropoxy-2-methylphenyl]piperidin-1-yl]pentan-2-one(related substance G),5-chloro-N2-[4-[1-[5-chloro-4-[[2-(isopropylsulfonyl)phenyl]amino]pyrimidin-2-yl]piperidin-4-yl]-2-isopropoxy-5-methylphenyl]-N4-[2-(isopropylsulfonyl)phenyl]pyrimidine-2,4-diamine(related substance H). And their structures were confirmed by 1H NMR and MS.

  • Xiaoping FANG, Haoxue ZHENG, Shan LU, Yan CAO
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 235-243.

    Amorphization is an effective method to improve the solubility and dissolution of poorly water-soluble drugs. However, the poor stability limits the further development of amorphous drugs. Therefore, this study aimed to explore the stability mechanism of the andrographolide-oxymatrine(AP-OMT) co-amorphous system from the perspective of molecular aggregation. At first, the AP-OMT co-amorphous system were prepared by solvent volatilization method. Then, molecular dynamics simulations were used to calculate and evaluate the compatibility within the components. Finally, Gaussian 16 software was used to calculate the bond energies and bond distances of molecular aggregates consisting of multiple hydrogen bonding modes in the co-amorphous AP-OMT, which were verified by stability investigation. Quantum computing studies revealed that dimer 4 had the largest interaction energy(with negative value) and the shortest hydrogen bond length, indicating that dimer 4 was the most stable aggregate in the co-amorphous system. Stability studies showed that the AP-OMT co-amorphous system was physically stable over a period of 12 months. This study revealed the stability mechanism of the binary co-amorphous system of AP-OMT and provided theoretical guidance for the stability study of this class of drugs.

  • Jin CAO, Renjie XU, Jianhua HE, Xuecheng XIAO, Shan LU
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 244-252.

    Erlotinib hydrochloride(1) is a novel tyrosine kinase inhibitor characterized by high permeability but low water solubility. The addition of small molecule ligands to prepare co-amorphous drug systems is an effective strategy to enhance the solubility, dissolution rate, and bioavailability of poorly water-soluble drugs. In this study, co-amorphous systems of 1 and L-tryptophan(2) were prepared by rotary evaporation method. The co-amorphous 1-2 system was characterized by Fourier transform infrared spectroscopy(FTIR), powder X-ray diffraction(PXRD), and differential scanning calorimetry(DSC). The PXRD and DSC results confirmed the formation of the co-amorphous system. And FTIR analysis and molecular dynamics simulations further suggested the presence of hydrogen bond interactions between 1 and 2, which could be the potential molecular mechanism for the formation of the co-amorphous system. Compared to the single crystal of 1, the solubility and dissolution rate of 1 in the 1-2 co-amorphous system were significantly improved. The results of pharmacokinetic modeling in SD rats showed that the cmax and AUC0→t of the co-amorphous system group were 2.8 times and 2.3 times higher than those of the bulk drug group, respectively. Meanwhile, there was no significant increase in the cmax and AUC0→t of the physical mixture group. In conclusion, the co-amorphous 1-2 system prepared in this study can significantly improve the solubility and oral bioavailability of 1.

  • Junwei JIA, Zhixiang ZHU, Zhengzhao LI, Yujiang PANG, Liping ZHANG, Zhong FENG
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 253-260.

    In this study, elagolix sodium self-developed tablets were formulated by optimizing three key formulation process parameters, namely the particle size of active pharmaceutical ingredient(API), the aperture of sieve screen in the dry granulation process, and the tablet hardness. The similarity factor (f2) values between the dissolution curves of the self-developed and reference tablets were calculated as a criterion for evaluation. The results indicated that when the API particle size[d(0.9)] was 250 μm, the aperture of sieve screen was 1.4 mm, and the tablet hardness was 80 N, the in vitro dissolution behavior of the self-developed tablets was similar to that of the reference formulations. Subsequently, bioequivalence was investigated using relevant permeation parameters from the parallel artificial membrane permeation assay(PAMPA) and pharmacokinetic characteristics in Beagle dogs. The results revealed that the permeation rates of the self-developed tablets and the reference formulations were 8.698 8 and 8.161 6 μg·mL–1·min–1 respectively, with membrane permeabilities of 2.24×10–4 and 2.10×10–4 cm/s. The confidence interval for the self-developed tablets ranged from 100.82% to 104.54%. There was no statistically significant difference in the pharmacokinetic parameters between the two groups(P>0.05). The relative bioavailability of the self-developed tablets was found to be (95.4±8.69)%, demonstrating the bioequivalence with the reference formulations.

  • Zhijun WANG, Ruiqi YUE, Qilei CHENG, Yanhai ZHANG, Huiyi LI
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 261-270.

    An ultra high performance liquid chromatography(UHPLC) method was established to determine the fifteen related substances in bromhexine hydrochloride(1). The Zorbax Eclipse Plus C18 column was used, with ammonium formate buffer-acetonitrile(60∶40) as the mobile phase. The final chromatographic conditions were screened out by examining the conditions such as mobile phase pH, buffer salt concentration, and column temperature. The UHPLC method and pharmacopoeia standard method were used to analyze and compare a total of sixteen batches of 1 bulk drugs and 1 tablets from three manufacturers, and high-resolution mass spectrometry was used to preliminarily infer the unknown impurities. The results showed that the fifteen related substances and principal component were well separated, and the products after forced degradation did not interfere with the separation of the target peak, indicating the good specificity of this method. All known impurities and total impurities in 1 bulk drugs and 1 tablets met the requirements of the pharmacopoeia. The unknown impurity was analyzed by LC-MS, and it was inferred that it might be 2,4-dibromo-6-[[methyl-(4-methylcyclohexyl)-amino]methyl]aniline. This method provided a reference for the consistency evaluation of 1.

  • Panpan WU, Chunhe WANG, Xiaoju JIANG, Yunfei YUE, Changyu WANG
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 271-274.

    An HPLC-ELSD method was established to determine the contents of phosphatidyl ethanolamine(2)and egg yolk phosphatidylcholine(3) in lecithin(1) tablets. The CAPCELL PAK C18 column(4.6 mm×250 mm,5 μm) was used, and the analysis was carried out in the gradient elution mode with methanol-water-glacial acetic acid-triethylamine(85∶15∶0.45∶0.05) as mobile phase A, and n-hexane-isopropanol-mobile phase A(20∶48∶32) as mobile phase B. The results showed that it was linear for 2 and 3 in the ranges of 2 - 50 and 20 - 400 μg/mL, respectively. The average recoveries(n=6) of 2 and 3 were 102.9% and 106.6%, respectively, with RSDs of 2.6% and 1.4%. The content determination results showed that in six batches of 1 tablets, the contents of 2 and 3 were 1.5 - 5.0 and 40.0 - 65.0 mg per tablet, respectively. The established method has good specificity and accuracy, which can be used for the determination of 2 and 3 in 1 tablets.

  • Xiaoyan SHI, Yujiang PANG, Zhixiang ZHU, Zengyu PAN, Liping ZHANG, Zhong FENG
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 275-282.

    An HPLC method was established for the determination of the related substances in carbidopa and levodopa sustained-release tablets. The Waters X-Bridge C18 column(4.6 mm×250 mm, 5 μm) was used, and the analysis was carried out in the gradient elution mode with pH 1.8 phosphate buffer solution as mobile phase A, and pH 1.8 phosphate buffer solution-methanol(250∶750) as mobile phase B. The flow rate was 1.0 mL/min, the detection wavelength was 280 nm, the column temperature was 25 ℃, and the injection volume was 20 μL. The results showed that the main peaks and related substance peaks could be well separated, and it was linear for carbidopa, levodopa, and the seven related substances. The average recoveries(n=9) of seven related substances were 98.97%, 100.79%, 102.69%,98.13%, 102.34%, 95.97%, and 100.80%, respectively. The results of the forced degradation tests showed that this method could indicate the degradation products under various conditions. This method has higher specificity, simplicity, and durability than the methods included in the USP 43. It can be used for the production control and stability sample determination of carbidopa and levodopa sustained release tablet.

  • Hua ZHENG, Honghua LU, Yanqin HE, Guizhou HAO, Guimin ZHANG
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 283-286.

    A gas chromatography-mass spectrometry(GC-MS) method was established to determine the genotoxic impurities of benzyl chloride(2) and benzyl dichloride(3) in fulvestrant injection(1). The VF-1ms capillary column(0.25 mm×30 m×0.25 μm) was used, and two monitoring modes were respectively adopted to measure 2(MRM) and 3(SIM). The results showed that it was linear for 2 and 3 in the ranges of 5.427 - 54.272 ng/mL, 4.775 -47.748 ng/mL, respectively. The LOQs of 2 and 3 were 2.714 and 2.387 ng/mL, and the LODs were 0.54 and 0.48 ng/mL, respectively. The average recoveries(n=9) of 2 and 3 were 99.43% and 99.09%, with the RSDs of 2.43% and 2.66%, respectively. The established GC-MS method can provide references for impurity research in 1.

  • Rong JIANG, Yujie ZHENG, Fei XU, Lele ZHANG, Rong SHAO
    Chinese Journal of Pharmaceuticals. 2024, 55(2): 287-291.
News